892
Can. J. Chem. Vol. 80, 2002
recorded on a Bruker Biflex III with 2>,4 >,6>-trihydroxy-
acetophenone monohydrate (THAP) as the matrix.
166.1, 165.8, 165.1 (PhCO), 135.0, 133.8, 133.5, 133.4,
132.2, 130.0, 129.9, 129.8, 128.6, 128.5, 128.5, 128.4 (aro-
matic C), 123.1 (C-Br), 85.8 (C-1), 79.0, 73.9, 70.5, 69.2,
61.5. MALDI-TOF MS calcd. for C33H27BrO8S: 662.06
[M(79Br)], 664.06 [M(81Br)]; found: 685.05 [M(79Br) +
Na]+, 687.06 [M(81Br) + Na]+, 701.03 [M(79Br) + K]+,
703.02 [M(81Br) + K]+.
Typical preparation of the donors
The peracetylated sugar (2.5 mmol, 1.0 equiv) was dis-
solved in dry CH2Cl2 (2 mL per mmol sugar). Thiol (1.2–1.5
equiv) and BF3·Et2O (1.5–2 equiv) were successively added.
When the reaction was complete (TLC: toluene–EtOAc, 3:1)
the reaction mixture was quenched with Et3N (2.5 equiv),
evaporated, and redissolved in CH2Cl2, then washed with
brine, dried, and concentrated. The crude product was fil-
tered through a plug of silica gel (toluene–EtOAc, 9:1) and
after crystallization (95% ethanol or pentane–Et2O) the ꢂ-
compounds were obtained. After removal of the acetates
with NaOMe, the crude material was benzoylated in
pyridine.
4-Bromophenyl (2,3,4,6-tetra-O-benzoyl--D-glucopyran-
osyl)-(1J6)-2,3,4-tri-O-benzoyl-1-thio--D-glucopyran-
oside (17)
A solution of donor Glc-13 (100 mg, 156 mol) and
acceptor 16 (100 mg, 150 mol) in dry CH2Cl2 (5 mL) was
stirred with powdered molecular sieves (4 Å, 200 mg) under
argon for 1 h, then DMTST (54 mg, 209 mol dissolved in
500 L CH2Cl2) was added. The reaction, followed by TLC
(toluene–EtOAc, 6:1), was quenched after 4 h by addition of
Et3N (100 L) and the mixture was diluted with CH2Cl2
(20 mL), filtered, and concentrated. The residue was sub-
jected to silica gel column chromatography (pentane–Et2O,
1:1 followed by toluene–EtOAc, 20:1) to obtain 17 (130 mg,
Competitive glycosylation experimental procedure
A mixture of the glycoside donor (10 mol, 1.0 equiv,
1 mmol in CH2Cl2), the reference donor (10 mol, 1.0 equiv,
1 mmol in CH2Cl2), the HPLC reference compound (5 mol,
0.5 equiv, ꢀ/ꢂ 17:83, 0.5 mmol in CH2Cl2), the acceptor
(20 mol, 2.0 equiv, 2 mmol in CH2Cl2), and molecular
sieves (4 Å) was stirred at room temperature for 30 min. An
HPLC sample (5 L) was taken, centrifuged, and analyzed.
DMTST (10 mol, 1.0 equiv., 1 mmol in CH2Cl2) was added
and HPLC samples (20 L) were taken at regular intervals
(first set: 30 min, 1 h, 2 h, 4 h, 24 h; second set: 1 h, 3 h),
centrifuged, and analyzed. All couplings were carried out as
a double experiment at the same time to minimize errors.
1
105 mol, 70%) as a white solid. H NMR ꢁ: 8.0–7.7 (m,
14H), 7.5–6.9 (m, 25H), 5.9 (t, J = 9.6 Hz, 1H), 5.8 (t, J =
9.4 Hz, 1H), 5.6 (t, J = 9.9 Hz, 1H), 5.5 (dd, J = 7.7, 9.9 Hz,
1H), 5.3 (t, J = 9.6 Hz, 1H), 5.2 (t, J = 9.9 Hz, 1H), 4.9 (d,
J = 7.7 Hz, 1H, H-1>), 4.8 (d, J = 9.9 Hz, 1H, H-1), 4.6 (dd,
J = 3.3, 12.1 Hz, 1H), 4.4 (dd, J = 4.4, 12.1 Hz, 1H), 4.0 (m,
3H), 3.9 (dd, J = 7.1, 11.5 Hz, 1H). 13C NMR ꢁ: 166.1,
165.9, 165.7, 165.4, 165.2, 165.0 (PhCO), 134.8, 133.6,
133.5, 133.4, 133.3, 132.2, 130.7, 130.0, 129.9, 129.8,
129.6, 129.3, 129.2, 128.9, 128.7, 128.5, 128.4, 128.3,
125.4, 123.0 (aromatic C), 101.5 (C-1>), 85.6 (C-1), 78.2,
74.1, 73.0, 72.5, 71.9, 70.5, 69.6, 68.7, 65.0. MALDI-TOF
MS calcd. for C67H53BrO17S: 1240.22 [M(79Br)], 1242.42
[M(81Br)]; found: 1263.25 [M(79Br) + Na]+, 1265.25
[M(81Br) + Na]+, 1279.24 [M(79Br) + K]+, 1281.25 [M(81Br) +
K]+.
4-Bromophenyl 2,3,4-tri-O-benzoyl-1-thio--D-glucopy-
ranoside (16)
4-Bromophenyl 1-thio-ꢂ-D-glucopyranoside (680 mg,
1.92 mmol), dissolved in pyridine (5 mL), was stirred with
TBDMSCl (350 mg, 2.3 mmol) and DMAP (cat.) at room
temperature over night (CHCl3–MeOH, 9:1). Then benzoyl
chloride (2 mL) was added and the mixture was left stirring
for additional 2 h (toluene–EtOAc, 6:1). After aqueous work-
up, the raw material was purified by silica gel flash-
chromatography (pentane–Et2O, 3:1) to yield 4-bromophenyl
2,3,4-tri-O-benzoyl-6-O-tert-butyldimethylsilyl-1-thio-ꢂ-D-glu-
copyranoside (1.34 g, 1.72 mmol, 90%). 1H NMR ꢁ: 8.3–7.1
(m, 19H), 5.9 (t, J = 9.3 Hz, 1H), 5.5 (t, J = 9.6 Hz, 1H), 5.4
(t, J = 9.9 Hz, 1H), 5.0 (d, J = 9.6 Hz, 1H, H-1), 4.0–3.8 (m,
3H), 0.9 (s, 9H, t-BuSi), 0.0 (2s, 6H, Me2Si). 13C NMR ꢁ:
165.9, 165.1, 165.1 (PhCO), 134.5, 133.8, 133.4, 132.1,
130.3, 129.9, 129.8, 128.5, 128.5, 128.3 (aromatic C), 122.8
(C-Br), 85.8 (C-1), 79.7, 74.5, 70.6, 69.1, 62.7, 25.9 (t-
BuSi), 18.4 (t-BuSi), –5.2, –5.3 (Me2Si).
To a cooled (0°C) solution of 4-bromophenyl 2,3,4-tri-O-
benzoyl-6-O-tert-butyldimethylsilyl-1-thio-ꢂ-D-glucopyranoside
(1.28 g, 1.65 mmol) in CH2Cl2 (50 mL), was slowly added
BF3·Et2O (520 L, 4.1 mmol). After 2 h, the reaction
mixture was diluted with CH2Cl2, washed consecutively
with H2O, NaHCO3, and brine, then dried and concentrated.
The crude product was purified by silica gel flash-
chromatography (toluene J toluene–EtOAc, 6:1) to yield 16
(0.94 g, 1.42 mmol, 86%). 1H NMR ꢁ: 8.0–7.8 (m, 6H), 7.6–
7.1 (m, 13H), 5.9 (t, J = 9.6 Hz, 1H), 5.4 (t, J = 9.6 Hz, 2H),
5.0 (d, J = 9.6 Hz, 1H, H-1), 3.9–3.7 (m, 3H). 13C NMR ꢁ:
Methyl (2,3,4,6-tetra-O-benzoyl--D-glucopyranosyl)-
(1J6)-(2,3,4-tri-O-benzoyl--D-glucopyranosyl)-(1J6)-
2,3,4-tri-O-benzyl-␣-D-glucopyranoside (18) (26)
A solution of donor 17 (40 mg, 32 mol) and acceptor 15
(18 mg, 39 mol) in dry CH2Cl2 (2 mL) was stirred with
powdered molecular sieves (4 Å, 100 mg) under argon for
1 h. The mixture was cooled (0°C) and NIS (11 mg,
49 mol) and AgOTf (cat.) were added. The reaction, fol-
lowed by TLC (toluene–EtOAc, 6:1), was quenched after
30 min by addition of Et3N (50 L), the mixture was then
diluted with CH2Cl2 (20 mL), filtered, and concentrated. The
residue was subjected to silica gel column chromatography
(toluene J toluene–EtOAc, 10:1) to yield 18 (42 mg,
1
28 mol, 88%). H NMR ꢁ: 8.0–7.7 (m, 14H), 7.5–6.9 (m,
36H), 5.8 (t, J = 10 Hz, 1H), 5.7 (t, J = 10 Hz, 1H), 5.6 (t,
J = 10 Hz, 1H), 5.4 (m~dd, J = 10 Hz, J = 8 Hz, 2H), 5.3 (t,
J = 10 Hz, 1H), 5.0 (d, J = 7.8 Hz, 1H,), 4.9 (d, J = 11 Hz),
4.7 (d, J = 12 Hz, 1H), 4.6 (d, J = 11 Hz, 1H), 4.5 (m, 3H),
4.4 (d, J = 8 Hz, 1H), 4.3 (m, 2H), 4.1 (d, J = 11 Hz, 1H),
4.0 (m, 2H), 3.8 (m, 4H), 3.5–3.3 (m, 4H), 3.3 (s, 3H) ppm.
13C NMR ꢁ: 166.1, 165.8, 165.4, 165.1, 164.9 (PhCO),
139.7–137.5, 133.5–127.4 (aromatic C), 101.5, 100.8 (C-1>,
C-1>>), 98.2 (C-1), 81.9, 79.8, 75.5, 74.5, 74.4, 73.5, 72.8,
© 2002 NRC Canada